RxDoctor Payments Data

Timothy Gardner, DPM

Podiatrist · Knoxville, TNNPI 1841249224

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Arthrex at 42.7% of the total. Reporting peaked in 2021 at $2,660 and has fallen 99.3% since, to $17 in 2025.

$3,733in general payments, 2019–2025

Across 65 payments — averaging $57.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Alpha Orthopedic Systems$1K
  • Novartis$287
  • Smith+Nephew$196
  • Paratek Pharmaceuticals, Inc.$94
  • Linvatec Corporation$91
  • plus $446 from 17 others

What the payments were for

  • Travel & lodging$1,02127%
  • Food & beverage$1,51240%
  • Education$1,20032%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,733 in reported general payments places this provider in the 75th percentile of 105 podiatrist providers in Tennessee.

See all podiatrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$117,584
Medicare patients
405
Services billed
1,421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl117$909
Linezolid19$797
Ciclopirox27$709
Ammonium Lactate32$632
Gabapentin72$620
Mupirocin49$449
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$308
Celecoxib16$266
Ketoconazole20$264
Prednisone17$173
Cilostazol13$164
Ondansetron Hcl45$124
Doxycycline Hyclate22$119
Amoxicillin43$85
Pregabalin12$77

Paid to pharmacies, not to this prescriber.

Other podiatrist in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →